Obesity

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Financial Aspect

Financial Aspect

Call for overhaul of drug industry business model.  Full Article 

Medical Decision

Medical Decision

U.S. doctor group votes to recognize obesity as a disease.  Full Article 

Swine Flu

Swine Flu

Outbreak of deadly piglet virus spreads to 13 U.S. states.  Full Article 

Breast Feeding

Breast Feeding

Venezuela considers taking bottles from babies' mouths.  Full Article 

E-cigarettes

E-cigarettes

Insight: No smoke, plenty of fire fuels e-cigarettes  Full Article 

New Diet

New Diet

New diet craze offers five days of feasting for two days of famine  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

Calorie overload sends the brain haywire: study

Related Topics

The new Xbox One controller (R), next to the previous controller during a press event unveiling Microsoft's new Xbox One in Redmond, Washington May 21, 2013. REUTERS/Nick Adams/Files
Technology

Microsoft reverses position on Xbox One

Microsoft says that users of its forthcoming Xbox One game console will be able to play games offline without an Internet connection, and will be able to lend or sell used disc-based games.  Full Article 

WASHINGTON | Fri Oct 3, 2008 12:35am IST

WASHINGTON (Reuters) - Overeating makes the brain go haywire, prompting a cascade of damage that may cause diabetes, heart disease and other ills, U.S. researchers reported on Thursday.

Eating too much appears to activate a usually dormant immune system pathway in the brain, sending out immune cells to attack and destroy invaders that are not there, Dongsheng Cai of the University of Wisconsin-Madison and colleagues found.

The finding, reported in the journal Cell, could help explain why obesity causes so many different diseases. It might also offer a way to prevent obesity itself.

"This pathway is usually present but inactive in the brain," Cai said in a statement.

Obesity is a growing global problem, with 1.8 billion people estimated to be overweight or obese in 2007. Drugs marketed so far to fight obesity have only limited success and, often, severe side-effects.

Cai's team worked in mice, seeking to explain studies that have shown that obesity causes chronic inflammation throughout the body. This inflammation is found in a range of diseases related to obesity, including heart disease and diabetes.

They homed in on a compound known as IKKbeta/NK-kappaB.

Immune cells such as macrophages and leukocytes use it but Cai's team found it in the hypothalamus, a part of the brain linked with metabolism in mice and humans alike.

"The hypothalamus is the 'headquarters' for regulating energy," they wrote.

They found high levels of the compound there but it was normally inactive.

When they fed mice a high-fat diet, it became extremely active. And when it was active, the body ignored signals from leptin, a hormone that normally helps regulate appetite, and insulin, which helps convert food into energy.

Stimulating IKKbeta/NK-kappaB made the mice eat more, while suppressing it made them eat less.

Cai believes his team has discovered a master switch for the diseases caused by overeating.

"Hypothalamic IKKb/NF-kB could underlie the entire family of modern diseases induced by overnutrition and obesity," his team wrote.

Cai does not know why this compound would be in the brain and in the immune system but suspects it evolved long ago in primitive animals that do not have the same sophisticated immune system as modern animals, including mice and humans.

"Presumably it played some role to guide the immune defense," Cai said in a telephone interview. "In today's society, this pathway is mobilized by a different environmental challenge -- overnutrition."

"Knocking out" the gene using genetic engineering kept mice eating normally and prevented obesity. This cannot be done in people but Cai believes a drug, or even gene therapy, might work.

With gene therapy, a virus or other so-called vector is used to carry corrective DNA into the body, but the approach is still highly experimental.

(Editing by Julie Steenhuysen and John O'Callaghan)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.